SEATTLE (AP) _ Immune Design Corp. (IMDZ) on Wednesday reported a loss of $13.8 million in its second quarter.
The Seattle-based company said it had a loss of 29 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
The biotechnology company posted revenue of $755,000 in the period.
In the final minutes of trading on Wednesday, the company's shares hit $3.55. A year ago, they were trading at $11.60.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDZ at https://www.zacks.com/ap/IMDZ